ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

09 Apr 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

31 Mar 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

19 Mar 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

18 Mar 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

14 Mar 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

03 Mar 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

28 Feb 2025 05:50:16 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 Feb 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 Feb 2025 15:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 Jan 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 Jan 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 Jan 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30 Dec 2024 15:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

26 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

08 Nov 2024 05:50:28 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

04 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

30 Oct 2024 16:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

25 Oct 2024 05:50:54 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

24 Oct 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

26 Sep 2024 05:50:00 By Nasdaq GlobeNewswire